Hologic INC Form 4 insider transactions

Hologic's Chief Operating Officer, Mitchell Essex D, reports acquiring shares of common stock and performance stock units.

John M. Griffin, General Counsel of Hologic Inc., reports acquiring 20,746 shares of common stock on November 5, 2024, increasing his total holdings to 187,227 shares.

Erik S. Anderson, Division President at Hologic, reports the acquisition of 4,149 shares of common stock on November 5, 2024, according to a Form 4 filing.

Hologic's Chief Financial Officer, Karleen Marie Oberton, executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Brandon Schnittker, Division President at Hologic Inc., sold 476 shares of common stock at an average price of $83.108 per share on August 6, 2024.

Benjamin Jordan Cohn, Principal Accounting Officer of Hologic Inc., reports the sale of 5,093 shares of common stock at an average price of $81.989 per share on August 1, 2024.

Hologic's CEO, Stephen Macmillan, executed stock options and sold shares on July 30, 2024, under a pre-arranged 10b5-1 trading plan.

Hologic's CEO, Stephen Macmillan, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Director Christiana Stamoulis exercised stock options and sold shares of Hologic Inc. under a pre-arranged Rule 10b5-1 trading plan.

Brandon Schnittker, Division President at Hologic Inc., reports disposition of 67 common stock shares to cover tax obligations.

Hologic's Chairman, President, and CEO, Stephen MacMillan, transferred 57,875 shares of common stock to the MacMillan Family Trust on May 23, 2024.

Hologic's CEO, Stephen Macmillan, reports transferring 24,000 shares of common stock to the MacMillan Family Trust in April 2024.

Director Garrett Scott T. of Hologic Inc. reports acquisition and disposal of common stock and exercise of stock options on March 14, 2024.

Director Charles J. Dockendorff reported the acquisition of restricted stock units and stock options, as well as the sale of common stock under a pre-arranged trading plan.

Director Sally Crawford reports acquisition and disposal of Hologic Inc. stock and stock options.

Director Amy McBride Wendell reports acquisition of Hologic common stock and stock options.

Director Stacey D. Stewart reports acquisition of common stock and stock options in Hologic Inc.

Director Christiana Stamoulis reported the acquisition of common stock and stock options in Hologic Inc. on March 7, 2024.

Director Nanaz Mohtashami reports acquisition of Hologic common stock and stock options.

Director Ludwig Hantson reports acquisition of common stock and stock options in Hologic Inc.

Director Garrett T. Scott reports acquisition of common stock and stock options in Hologic Inc.